MIRA Pharmaceuticals Completes Phase 1 Dosing of Ketamir-2
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| Miracle Applications Corp (NASDAQ: MIRA) | Delayed: 0.67 -0.04 (5.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.71 | 52 Week High | $0.04 | |||
| Open | $0.70 | 52 Week Low | $0.00 | |||
| Day High | $0.70 | P/E | N/A | |||
| Day Low | $0.66 | EPS | $0.00 | |||
| Volume | 67,695 | |||||
